Tolerability, Safety and Pharmacokinetics Study of GX-30 in Total Thyroidectomy or Near Total Thyroidectomy Patients

NCT03276988 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Total Thyroidectomy
Near-total Thyroidectomy

Interventions

DRUG: Period 1 GX-30, Period 2 THYROGEN®
DRUG: Period 1 THYROGEN®, Period 2 GX-30

Sponsor

Genexine, Inc.

Collaborators

[object Object]